We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+11.92%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.56B
AUM Growth
+$200M
Cap. Flow
-$12.2M
Cap. Flow %
-0.48%
Top 10 Hldgs %
35.03%
Holding
185
New
38
Increased
44
Reduced
32
Closed
58

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$34.8M
2
AGN.PRA
Allergan plc
AGN.PRA
+$31.9M
3
EBAY icon
eBay
EBAY
+$28.5M
4
YUM icon
Yum! Brands
YUM
+$27.1M
5
HES
Hess
HES
+$22.8M

Top Sells

Rank Stock Value
1
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$29.6M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$23M
3
SNV
Synovus
SNV
+$21.7M
4
BLMN icon
Bloomin' Brands
BLMN
+$21.2M
5
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Consumer Discretionary 10.07%
3 Technology 9.69%
4 Consumer Staples 5.72%
5 Industrials 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRCX icon
51
Lam Research
LRCX
$367B
$16.5M 0.65%
2,033,000
+1,020,450
+101% +$8.01M
BUD icon
52
AB InBev
BUD
$170B
$16.1M 0.63%
133,450
+11,000
+9% +$1.35M
BERY
53
DELISTED
Berry Global Group, Inc.
BERY
$15.9M 0.62%
+536,006
New +$16.8M
AWH
54
DELISTED
Allied World Assurance Co Hld Lt
AWH
$15.9M 0.62%
367,103
+2,300
+0.6% +$97.4K
FATE icon
55
Fate Therapeutics
FATE
$286M
$15.6M 0.61%
2,407,412
+884,137
+58% +$5.29M
JAH
56
DELISTED
JARDEN CORPORATION
JAH
$15.5M 0.61%
300,266
-107,876
-26% -$5.71M
GIMO
57
DELISTED
Gigamon Inc.
GIMO
$15M 0.59%
455,000
-459,586
-50% -$13.6M
SPB icon
58
Spectrum Brands
SPB
$2.04B
$15M 0.58%
146,627
+78,400
+115% +$7.37M
EHC icon
59
Encompass Health
EHC
$11B
$14.2M 0.56%
388,664
+85,476
+28% +$3.05M
TAP.A icon
60
CALL
Molson Coors Class A
TAP.A
$14M 0.55%
+200,000
New +$16.1M
ARAV
61
DELISTED
Aravive, Inc. Common Stock
ARAV
$13.6M 0.53%
149,255
+30,348
+26% +$3.07M
DISH
62
DELISTED
DISH Network Corp.
DISH
$13.5M 0.53%
200,000
-8,000
-4% -$559K
BURL icon
63
Burlington
BURL
$23.2B
$13.5M 0.53%
+263,000
New +$14.1M
CL icon
64
CALL
Colgate-Palmolive
CL
$73.1B
$13.1M 0.51%
+200,000
New +$13.6M
XOMA
65
DELISTED
Xoma
XOMA
$12.7M 0.5%
163,656
-214,947
-57% -$15.5M
PLXP
66
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$12.4M 0.48%
121,388
+32,350
+36% +$3.35M
TSNU
67
DELISTED
Tyson Foods, Inc.
TSNU
$12.1M 0.47%
235,000
+35,000
+18% +$1.77M
DVAX
68
DELISTED
Dynavax Technologies
DVAX
$12M 0.47%
512,341
+277,341
+118% +$6.04M
HAIN icon
69
Hain Celestial
HAIN
$45M
$11.6M 0.45%
176,000
-25,246
-13% -$1.59M
THC icon
70
CALL
Tenet Healthcare
THC
$20.5B
$11.6M 0.45%
200,000
– –
EAT icon
71
CALL
Brinker International
EAT
$9.17B
$11.5M 0.45%
+200,000
New +$11.4M
ZLTQ
72
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$11.4M 0.44%
385,775
-219,462
-36% -$6.63M
HOG icon
73
PUT
Harley-Davidson
HOG
$2.58B
$11.3M 0.44%
200,000
-100,000
-33% -$5.72M
NXPI icon
74
NXP Semiconductors
NXPI
$57.8B
$10.8M 0.42%
+110,400
New +$11.3M
NOW icon
75
PUT
ServiceNow
NOW
$115B
$10.4M 0.41%
+700,000
New +$10.8M
1 2
3
4 5

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM

Kingdon Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Kingdon Capital Management held 185 positions worth $2.56B, up 8.5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kingdon Capital Management's Q2 2015 filing shows 38 new, 44 increased, 32 reduced and 58 closed positions. Its largest new stake was Allergan plc: 30,500 shares worth $31.9M. The largest sale was ANACOR PHARMACEUTICALS INC COM, an estimated $29.6M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Kingdon Capital Management's largest Q2 2015 buy was Allergan plc: 30,500 shares worth $31.9M.
  • Kingdon Capital Management added most to Adobe in Q2 2015, an estimated $34.8M increase.
  • Kingdon Capital Management's biggest Q2 2015 reduction was ANACOR PHARMACEUTICALS INC COM, cutting an estimated $29.6M.
  • Kingdon Capital Management fully exited BROADCOM CORP CL-A in Q2 2015, selling an estimated $23M.
  • Kingdon Capital Management's ten largest holdings make up 35% of its $2.56B portfolio in Q2 2015.
  • Kingdon Capital Management opened 38 new positions and closed 58 in Q2 2015.
  • Kingdon Capital Management's portfolio value rose 8.5% quarter-over-quarter to $2.56B.

Based on Kingdon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.